SC
IMA

Shay Capital’s ImageneBio Inc IMA Stock Holding History

Shay Capital’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$95.7K Sell
19,130
-4,086
-18% -$26.5K 0.01% 438
2025
Q4 		$160K Buy
+23,216
New +$172K 0.02% 426

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Shay Capital's IMA Position: Q1 2026 in Review

Shay Capital reduced its ImageneBio Inc (IMA) stake by 18% in Q1 2026, selling an estimated $26.5K and leaving 19,130 shares worth $95.7K. The position accounts for 0.01% of the portfolio, ranked #438.

Shay Capital first reported a position in IMA in Q4 2025 and has held it in 2 quarters since. The position peaked at $160K in Q4 2025. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • Shay Capital held 19,130 shares of ImageneBio Inc worth $95.7K as of Q1 2026.
  • Shay Capital sold 4,086 ImageneBio Inc shares in Q1 2026, an estimated $26.5K.
  • ImageneBio Inc made up 0.01% of Shay Capital's portfolio in Q1 2026, its #438 holding.
  • Shay Capital first reported a position in ImageneBio Inc in Q4 2025 and has held it in 2 quarters since.
  • Shay Capital's ImageneBio Inc position peaked at $160K in Q4 2025.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on Shay Capital's 13F filing for Q1 2026, filed 15 May 2026.